- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hereditary angioedema (HAE)
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 760KB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 169KB)
Garadacimab – November 2024
Garadacimab; Injection 200 mg in 1.2 mL pre-filled pen; Andembry®
Last updated
30 May 2025